EUS Procedures Using RIVOS™ EUS Access Device
Recruiting
Observational Study
Pancreatic Fluid Collections
Biliary Obstruction
Pancreatic Duct Obstruction
Chronic Pancreatitis
Pancreatic Cancer Non-resectable
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Orlando Health, Inc. · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* All patients undergoing EUS-guided interventions using the RIVOS™ EUS access device
Exclusion Criteria:
* Age \< 18 years
* Patients who did not undergo EUS-guided interventions using the RIVOS™ EUS access device
Contacts